DEVELOPMENT AND CHARACTERIZATION OF LAPATINIB CUBOSOMAL DRUG DELIVERY SYSTEM

The present study aimed to formulate, characterize, and evaluate Lapatinib-loaded cubosomes as a sustained-release nanocarrier system to improve the solubility, bioavailability, and therapeutic efficacy of Lapatinib. Cubosomes were prepared by the Top-Down method using glyceryl monostearate (GMS) as the lipid and Pluronic F-127 as the stabilizer. Eight formulations (F1–F8) were developed by varying the lipid concentration while maintaining a constant drug and surfactant ratio. SEM analysis revealed uniformly distributed, nearly spherical cubosomes with smooth surfaces. Particle size ranged from 220 to 279 nm, while zeta potential varied from −23 to −30 mV, indicating good colloidal stability. Among all formulations, F8 exhibited the smallest particle size (220 nm), highest entrapment efficiency (94.58%), and maximum cumulative drug release (98.76% after 12 hours). Drug release kinetic analysis demonstrated that the optimized formulation best fitted the Higuchi model (R² = 0.998), indicating diffusion-controlled sustained drug release. Accelerated stability studies conducted according to ICH guidelines showed no significant changes in the physical appearance or drug release profile, with the optimized formulation retaining more than 95% drug release after three months of storage. The findings indicate that the optimized Lapatinib-loaded cubosomal formulation is a stable and promising sustained-release drug delivery system with the potential to enhance oral bioavailability, therapeutic efficacy, and patient compliance in the management of cancer. Keywords: Lapatinib, cubosomes, Top-Down method, Glyceryl monostearate, In vitro drug release studies

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-20
DOI
https://doi.org/10.5281/zenodo.24403818
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

DEVELOPMENT AND CHARACTERIZATION OF LAPATINIB CUBOSOMAL DRUG DELIVERY SYSTEM

G. Kusuma, Gundlapally Hari Kiriti Varma*, Dr. Vijaya Kuchana
1 links
Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

DEVELOPMENT AND CHARACTERIZATION OF LAPATINIB CUBOSOMAL DRUG DELIVERY SYSTEM

G. Kusuma, Gundlapally Hari Kiriti Varma*, Dr. Vijaya Kuchana
article en

Abstract

The present study aimed to formulate, characterize, and evaluate Lapatinib-loaded cubosomes as a sustained-release nanocarrier system to improve the solubility, bioavailability, and therapeutic efficacy of Lapatinib. Cubosomes were prepared by the Top-Down method using glyceryl monostearate (GMS) as the lipid and Pluronic F-127 as the stabilizer. Eight formulations (F1–F8) were developed by varying the lipid concentration while maintaining a constant drug and surfactant ratio. SEM analysis revealed uniformly distributed, nearly spherical cubosomes with smooth surfaces. Particle size ranged from 220 to 279 nm, while zeta potential varied from −23 to −30 mV, indicating good colloidal stability. Among all formulations, F8 exhibited the smallest particle size (220 nm), highest entrapment efficiency (94.58%), and maximum cumulative drug release (98.76% after 12 hours). Drug release kinetic analysis demonstrated that the optimized formulation best fitted the Higuchi model (R² = 0.998), indicating diffusion-controlled sustained drug release. Accelerated stability studies conducted according to ICH guidelines showed no significant changes in the physical appearance or drug release profile, with the optimized formulation retaining more than 95% drug release after three months of storage. The findings indicate that the optimized Lapatinib-loaded cubosomal formulation is a stable and promising sustained-release drug delivery system with the potential to enhance oral bioavailability, therapeutic efficacy, and patient compliance in the management of cancer. Keywords: Lapatinib, cubosomes, Top-Down method, Glyceryl monostearate, In vitro drug release studies

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon